BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6253842)

  • 1. Influence of vasoactive intestinal polypeptide on net water flux and cyclic adenosine 3',5'-monophosphate formation in the rat jejunum.
    Beubler E
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Sep; 313(3):243-7. PubMed ID: 6253842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by morphine of prostaglandin E1-stimulated secretion and cyclic adenosine 3',5'-monophosphate formation in the rat jejunum in vivo.
    Beubler E; Lembeck F
    Br J Pharmacol; 1980 Mar; 68(3):513-8. PubMed ID: 6301596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa.
    Schwartz CJ; Kimberg DV; Sheerin HE; Field M; Said SI
    J Clin Invest; 1974 Sep; 54(3):536-44. PubMed ID: 4369434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat.
    Carter RF; Bitar KN; Zfass AM; Makhlouf GM
    Gastroenterology; 1978 Apr; 74(4):726-30. PubMed ID: 204536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative studies of vasoactive intestinal peptide (VIP) binding sites and VIP-induced adenosine 3':5'-monophosphate production in epithelial cells from duodenum, jejunum, ileum, cecum, colon and rectum in the rat.
    Prieto JC; Laburthe M; Hoa DH; Rosselin G
    Acta Endocrinol (Copenh); 1981 Jan; 96(1):100-6. PubMed ID: 6257013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
    Prieto JC; Guerrero JM; de Miguel C; Goberna R
    Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic adenosine monophosphate is the second messenger of prostaglandin E2- and vasoactive intestinal polypeptide-stimulated active bicarbonate secretion by guinea-pig duodenum.
    Reimer R; Odes HS; Muallem R; Schwenk M; Beil W; Sewing KF
    Scand J Gastroenterol; 1994 Feb; 29(2):153-9. PubMed ID: 8171284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide promotes cyclic adenosine 3',5'-monophosphate accumulation in guinea-pig trachea.
    Frandsen EK; Krishna GA; Said SI
    Br J Pharmacol; 1978 Mar; 62(3):367-9. PubMed ID: 205290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
    Nakaki T; Nakadate T; Yamamoto S; Kato R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):637-41. PubMed ID: 6121049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of sodium and water secretion without inhibition of glucose absorption in the rat jejunum by vasoactive intestinal peptide (VIP).
    Coupar IM
    Clin Exp Pharmacol Physiol; 1976; 3(6):615-8. PubMed ID: 1009696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase-activating polypeptide stimulates cardiodilatin/atrial natriuretic peptide (CDD/ANP-(99-126) secretion from cultured neonatal rat myocardiocytes.
    Bäsler I; Kuhn M; Müller W; Forssmann WG
    Eur J Pharmacol; 1995 Nov; 291(3):335-42. PubMed ID: 8719418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal polypeptide stimulation of cyclic AMP formation in rat central nervous system.
    Kaneko T; Nakaya S; Saito S; Yanaihara N; Oka H
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():7-10. PubMed ID: 6112141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1.
    Emami S; Gespach C; Forgue-Lafitte ME; Broer Y; Rosselin G
    Life Sci; 1983 Aug; 33(5):415-23. PubMed ID: 6192308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive intestinal peptide on production of adenosine 3':5'-monophosphate.
    Laburthe M; Prieto JC; Amiranoff B; Dupont C; Hui Bon Hoa D; Rosselin G
    Eur J Biochem; 1979 May; 96(2):239-48. PubMed ID: 88368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine.
    Camilleri M; Cooper BT; Adrian TE; Bloom SR; Chadwick VS
    Gut; 1981 Jan; 22(1):14-8. PubMed ID: 6257593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a vasoactive intestinal peptide-sensitive adenylate cyclase in rat intestinal epithelial cell membranes.
    Amiranoff B; Laburthe M; Dupont C; Rosselin G
    Biochim Biophys Acta; 1978 Dec; 544(3):474-81. PubMed ID: 728466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of intracellular cyclic AMP and stimulation of adenylate cyclase activity by vasoactive intestinal peptide and glucagon in the retinal pigment epithelium.
    Koh SW; Chader GJ
    J Neurochem; 1984 Dec; 43(6):1522-6. PubMed ID: 6092540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal polypeptide-sensitive cyclic adenosine monophosphate generating system in the rat portal vein.
    Amenta D; Iacopino L; Amenta F
    Arch Int Pharmacodyn Ther; 1988; 291():88-95. PubMed ID: 2835024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of intestinal secretion without reduction of cyclic AMP levels.
    Lee MK; Coupar IM
    Eur J Pharmacol; 1980 Dec; 68(4):501-3. PubMed ID: 6258936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on cyclic AMP accumulation in sheep pituitary cells in vitro.
    Sawangjaroen K; Sernia C; Curlewis JD
    J Endocrinol; 1996 Mar; 148(3):545-52. PubMed ID: 8778233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.